Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes
Meghan Tahbaz, Eiji Yoshihara
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

New Insights and Potential Therapeutic Interventions in Metabolic Diseases
Vicente Javier Clemente‐Suárez, Alexandra Martín-Rodríguez, Laura Redondo-Flórez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10672-10672
Open Access | Times Cited: 51
Landscape of human organoids: Ideal model in clinics and research
Xinxin Han, Chunhui Cai, Wei Deng, et al.
The Innovation (2024) Vol. 5, Iss. 3, pp. 100620-100620
Open Access | Times Cited: 29
Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
Xin-xing Wan, Dan-Yi Zhang, Md. Asaduzzaman Khan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 45
Immune Evasion in Stem Cell-Based Diabetes Therapy—Current Strategies and Their Application in Clinical Trials
Razik Mu-u-min, Abdoulaye Diané, Asma Allouch, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 383-383
Open Access | Times Cited: 1
Making human pancreatic islet organoids: Progresses on the cell origins, biomaterials and three-dimensional technologies
Lai Jiang, Yiru Shen, Yajing Liu, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1537-1556
Open Access | Times Cited: 28
The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes
Maleesha Jayasinghe, Omesh Prathiraja, Prashan B Perera, et al.
Cureus (2022)
Open Access | Times Cited: 24
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
Xue Wang, Ziyuan Zeng, Dayan Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 1
Open Access
A perfect islet: reviewing recent protocol developments and proposing strategies for stem cell derived functional pancreatic islets
Sujitha Sali, Leen Azzam, Taraf Jaro, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
From Edmonton to Lantidra and beyond: immunoengineering islet transplantation to cure type 1 diabetes
Elhadji Malick Mbaye, Evan A. Scott, Jacqueline A. Burke
Frontiers in Transplantation (2025) Vol. 4
Open Access
Scaling Insulin-Producing Cells by Multiple Strategies
J. S. Choi, Fritz Cayabyab, H. Daniel Perez, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 191-205
Open Access | Times Cited: 3
Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus
Prakriti Siwakoti, Claire Rennie, Yanan Huang, et al.
Stem Cell Reviews and Reports (2022) Vol. 19, Iss. 3, pp. 601-624
Closed Access | Times Cited: 14
Islet transplantation into brown adipose tissue can delay immune rejection
Jessica D. Kepple, Jessie M. Barra, Martin E. Young, et al.
JCI Insight (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 13
The hope, hype and obstacles surrounding cell therapy
Cezary Tręda, Aneta Włodarczyk, Piotr Rieske
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 2
Advanced therapy to cure diabetes: mission impossible is now possible?
Rokhsareh Rohban, Christina Martins, Farzad Esni
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Benefits and Hurdles of Pancreatic β-Cell Replacement
Andrea Mario Bolla, Laura Montefusco, Ida Pastore, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 10, pp. 1029-1039
Open Access | Times Cited: 11
Stem Cell-Derived Islets for Type 2 Diabetes
Andrew Salib, Fritz Cayabyab, Eiji Yoshihara
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5099-5099
Open Access | Times Cited: 10
Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus
Pengxiu Dai, Guixiang Qi, Haojie Xu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Stem cell-derived islet therapy: is this the end of the beginning?
Veronica A. Cochrane, Matthias Hebrok
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 12, pp. 681-682
Closed Access | Times Cited: 4
Therapeutic approaches of cell therapy based on stem cells and terminally differentiated cells: Potential and effectiveness
Ali Pirsadeghi, Negar Namakkoobi, Mahtab Sharifzadeh Behzadi, et al.
Cells and Development (2024) Vol. 177, pp. 203904-203904
Closed Access | Times Cited: 1
Developments in endoderm and pancreatic β-cell differentiation from human pluripotent stem cells
Dong Hyeon Lee, Hwajung Choo, Hyo Yi Choi, et al.
Organoid (2024) Vol. 4, pp. e5-e5
Open Access | Times Cited: 1
Genome editing for engineering stem cell-derived pancreatic β cells: recent trends and future perspectives
Seeun Jang, Siyoon Shin, Yujin Jeong, et al.
Organoid (2023) Vol. 3, pp. e16-e16
Open Access | Times Cited: 2
Adapting Physiology in Functional Human Islet Organogenesis
Eiji Yoshihara
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4
Exploring the Role of Stem Cell Therapy in Diabetes: From Benchside Research to Clinical Applications and Beyond
Manisha Walde, Priti S Bhoyar, Ujwala Wasnik, et al.
Deleted Journal (2024) Vol. 15, Iss. 3, pp. 68-83
Open Access
Knockout of B2M in combination with PD-L1 overexpression protects MSC-derived new islet β cells from graft rejection in the treatment of canine diabetes mellitus
Pengxiu Dai, Yi Wu, Qingjie Du, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access
Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes
Eiji Yoshihara
Annals of Translational Medicine (2024) Vol. 12, Iss. 6, pp. 121-121
Open Access
Page 1 - Next Page

Scroll to top